Fennec Pharmaceuticals (FENC) Other Non-Current Assets (2021 - 2025)
Fennec Pharmaceuticals (FENC) posted Other Non-Current Assets of $717000.0 for Q4 2025, down 3.5% on a QoQ basis from $743000.0 in Q3 2025, and down 12.77% year-over-year from $822000.0 in Q4 2024.
Fennec Pharmaceuticals (FENC) Other Non-Current Assets (2021 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $717000.0 for Q4 2025.
- Quarterly Other Non-Current Assets fell 12.77% year-over-year to $717000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $717000.0 (down 12.77% YoY) and the FY2025 annual result came in at $717000.0, down 12.77% from the prior year.
- Other Non-Current Assets was $717000.0 for Q4 2025 at Fennec Pharmaceuticals, down from $743000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.0 million in Q1 2024 and bottomed at $14000.0 in Q2 2022.
- A 5-year average of $526812.5 and a median of $730000.0 in 2025 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 833.02% — and 2025, when it fell 22.35%.
- Fennec Pharmaceuticals' Other Non-Current Assets stood at $27000.0 in 2021, then jumped by 681.48% to $211000.0 in 2022, then jumped by 286.73% to $816000.0 in 2023, then gained by 0.74% to $822000.0 in 2024, then slipped by 12.77% to $717000.0 in 2025.
- Business Quant data shows FENC's Other Non-Current Assets at $717000.0 in Q4 2025, $743000.0 in Q3 2025, and $768000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | 717,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 717,000.00 |
| Sep 30, 2025 | 743,000.00 |
| Jun 30, 2025 | 768,000.00 |
| Mar 31, 2025 | 794,000.00 |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 956,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 816,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 27,000.00 |